{"id":685020,"date":"2026-05-26T15:23:29","date_gmt":"2026-05-26T07:23:29","guid":{"rendered":"https:\/\/law.asia\/?p=685020"},"modified":"2026-05-27T11:13:47","modified_gmt":"2026-05-27T03:13:47","slug":"ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition","status":"publish","type":"post","link":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/","title":{"rendered":"YKVN\u00b7Allens, 3400\uc5b5 \uaddc\ubaa8 SK\uadf8\ub8f9 \uc81c\uc57d\uc0ac \ub9e4\uac01 \uac70\ub798 \uc790\ubb38"},"content":{"rendered":"<p>YKVN\uacfc Allens\uac00 \uacf5\uac1c\ub9e4\uc218\ub97c \ud1b5\ud574 \ubca0\ud2b8\ub0a8 \uc81c\uc57d \ub300\uae30\uc5c5 Imexpharm\uc758 \uacbd\uc601\uad8c \uc9c0\ubd84\uc744 \uc778\uc218\ud55c Lian SGP \uce21\uacfc \ub9e4\ub3c4\uc778 \ud55c\uad6d SK\uadf8\ub8f9\uc744 \uac01\uac01 \uc790\ubb38\ud588\ub2e4.<\/p>\n<p>\ucd5c\uadfc \ub2e4\uc218 \uc5b8\ub860 \ubcf4\ub3c4\uc5d0 \ub530\ub974\uba74 \uc911\uad6d Livzon Pharmaceutical Group\uc774 \uc804\uc561 \ucd9c\uc790\ud55c \uc2f1\uac00\ud3ec\ub974 \uc18c\uc7ac \ubc95\uc778 Lian SGP\ub294 \uc57d 6\uc870\ub3d9(\uc57d 2\uc5b5 2,700\ub9cc \ub2ec\ub7ec, \uc57d 3,400\uc5b5\uc6d0)\uc5d0 Imexpharm \uc8fc\uc2dd 1\uc5b5450\ub9cc\uc8fc\ub97c \ub9e4\uc785\ud574 \ud68c\uc0ac \uc9c0\ubd84 67.8%\ub97c \ud655\ubcf4\ud588\ub2e4.<\/p>\n<p>YKVN\uc740 \ud638\ucc0c\ubbfc\uc2dc \uae30\ubc18\uc758 Managing Partner\uc778 TRUONG Nhat Quang \ubc0f \ud30c\ud2b8\ub108 \ubcc0\ud638\uc0ac HO Anh Tuyet \ub4f1\uc774 \uc8fc\ub3c4\ud574 Lian SGP \uce21\uc758 \ubca0\ud2b8\ub0a8 \uaddc\uc81c \ubc0f \ucef4\ud50c\ub77c\uc774\uc5b8\uc2a4 \uad00\ub828 \uc0ac\uc548\uc744 \uc790\ubb38\ud588\ub2e4.<\/p>\n<p>HO \ubcc0\ud638\uc0ac\ub294 <em>Asia Business Law Journal<\/em>\uc5d0 \u201c\uc774\ubc88 \uc790\ubb38\uc740 \uacf5\uac1c\ub9e4\uc218 \uad6c\uc870 \uc124\uacc4\uc640 \ubb38\uc11c\ud654, \uac70\ub798 \uc2e4\ud589, \uc758\ubb34\uc801 \uc18c\uc218\uc8fc\uc8fc \uac15\uc81c\ub9e4\uc218 \uc808\ucc28 \ubc0f \uad00\ub828 \uaddc\uc81c \uc81c\ud55c\uc0ac\ud56d, \uc0c1\uc7a5\ud3d0\uc9c0 \uac80\ud1a0, \uae30\uc5c5\uacb0\ud569 \uc2e0\uace0, \uac70\ub798 \uc885\uacb0 \uc774\ud6c4 \uc6d0\ud65c\ud55c \uacbd\uc601\uad8c \uc774\uc804\uc744 \uc704\ud55c \uc9c0\ubc30\uad6c\uc870 \uc815\ube44 \ub4f1\uc744 \ud3ec\ud568\ud588\ub2e4\u201d\uace0 \ub9d0\ud588\ub2e4.<\/p>\n<p>\uadf8\ub294 \uc774\ubc88 \uac70\ub798\uac00 \uaddc\uc81c\uae30\uad00 \ubc0f \uc774\ud574\uad00\uacc4\uc790\ub4e4\uacfc \uc870\uc728\uc744 \ud3ec\ud568\ud55c \uc5ec\ub7ec \ud575\uc2ec \uc694\uc18c\ub97c \uc218\ubc18\ud588\ub2e4\uace0 \uc124\uba85\ud588\ub2e4.<\/p>\n<p>\uadf8\ub294 \u201c\uc774\ubc88 \uac70\ub798\uc758 \uc8fc\uc694 \ud2b9\uc9d5 \uc911 \ud558\ub098\ub294 \uacf5\uac1c\ub9e4\uc218 \uad6c\uc870\uc640 \uad00\ub828\ud574 \uc5ec\ub7ec \uaddc\uc81c \uc808\ucc28\ub97c \ub3d9\uc2dc\uc5d0 \uc870\uc728\ud574\uc57c \ud588\ub2e4\ub294 \uc810\u201d\uc774\ub77c\uba70 \u201c\ud2b9\ud788 \uae30\uc5c5\uacb0\ud569 \uc2b9\uc778\uacfc \uad00\ub828\ud574 \ubca0\ud2b8\ub0a8 \uad6d\uac00\uc99d\uad8c\uc704\uc6d0\ud68c \ubc0f \uad6d\uac00\uacbd\uc7c1\uc704\uc6d0\ud68c\uc640 \uae34\ubc00\ud788 \ud611\uc758\ud574\uc57c \ud588\ub2e4\u201d\uace0 \ub9d0\ud588\ub2e4.<\/p>\n<p>\uc774\uc5b4 \u201c\ub610 \ub2e4\ub978 \ud2b9\uc9d5\uc740 \uad6d\uc601\uae30\uc5c5\uc774 Imexpharm\uc758 \uc8fc\uc694 \uc8fc\uc8fc\ub85c \ucc38\uc5ec\ud558\uace0 \uc788\uc5c8\ub2e4\ub294 \uc810\u201d\uc774\ub77c\uba70 \u201c\uac70\ub798 \uc804(\u5168) \uacfc\uc815\uc5d0\uc11c \ub2e4\uc218\uc758 \uc774\ud574\uad00\uacc4\uc790 \uac04 \uae34\ubc00\ud55c \uc870\uc728\uc774 \ud544\uc694\ud588\ub2e4\u201d\uace0 \uc124\uba85\ud588\ub2e4. \ub610 \u201c\uaddc\uc81c \uc808\ucc28\uc640 \uc774\ud574\uad00\uacc4\uc790 \ub300\uc751\uc744 \ud6a8\uacfc\uc801\uc73c\ub85c \uad00\ub9ac\ud558\ub294 \uac83\uc740 \uac70\ub798 \uc131\uacf5\uc758 \ud575\uc2ec \uc694\uc18c\uc600\ub2e4\u201d\uace0 \ub367\ubd99\uc600\ub2e4.<\/p>\n<p>Allens\ub294 \uae00\ub85c\ubc8c \uc81c\ud734 \ub85c\ud38c\uc778 Linklaters\uc640 \uae34\ubc00\ud788 \ud611\ub825\ud574 SK\uadf8\ub8f9 \uce21\uc758 \uc2f1\uac00\ud3ec\ub974 \ubc0f \uc911\uad6d\ubc95 \uad00\ub828 \uc0ac\uc548\uc744 \uc790\ubb38\ud588\ub2e4. \uc790\ubb38\ud300\uc740 \ubca0\ud2b8\ub0a8 \ucd1d\uad04 Linh BUI \ud30c\ud2b8\ub108 \ubcc0\ud638\uc0ac\ub97c \ube44\ub86f\ud574 \uc2dc\ub2c8\uc5b4 \uc18c\uc18d \ubcc0\ud638\uc0acThuy Linh NGUYEN, Ngoc NGUYEN, \uadf8\ub9ac\uace0 \uc18c\uc18d \ubcc0\ud638\uc0ac DUONG Anh\uacfc Tien TRAN \ub4f1\uc73c\ub85c \uad6c\uc131\ub410\ub2e4.<\/p>\n<p>\uc774\ubc88 \uac70\ub798\ub294 \uc678\uad6d\uacc4 \uc804\ub7b5\uc801 \ud22c\uc790\uc790\uac00 \ubca0\ud2b8\ub0a8 \uc0c1\uc7a5\uc0ac\uc758 \uacbd\uc601\uad8c \uc9c0\ubd84\uc744 \ub9e4\uac01\ud55c \ub4dc\ubb38 \uc0ac\ub840\ub85c \ud3c9\uac00\ub41c\ub2e4.<\/p>\n<p>\uc778\uc218 \uc774\ud6c4 Lian SGP \uce21\uc740 Imexpharm\uc758 \uae30\uc874 \uc0ac\uc5c5 \uc804\ub7b5\uc744 \uc720\uc9c0\ud558\ub294 \ud55c\ud3b8, EU-GMP \uae30\uc900\uc5d0 \ub530\ub77c \uc81c\uc870\ub41c \uc758\uc57d\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \uae30\ubc18\uc73c\ub85c \uc0ac\uc5c5\uc744 \ud655\ub300\ud574 \ub098\uac08 \uacc4\ud68d\uc774\ub2e4.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>YKVN\uacfc Allens\uac00 \uacf5\uac1c\ub9e4\uc218\ub97c \ud1b5\ud574 \ubca0\ud2b8\ub0a8 \uc81c\uc57d \ub300\uae30\uc5c5 Imexpharm\uc758 \uacbd\uc601\uad8c \uc9c0\ubd84\uc744 \uc778\uc218\ud55c Lian SGP \uce21\uacfc \ub9e4\ub3c4\uc778 \ud55c\uad6d SK\uadf8\ub8f9\uc744 \uac01\uac01 \uc790\ubb38\ud588\ub2e4. \ucd5c\uadfc \ub2e4\uc218 \uc5b8\ub860 \ubcf4\ub3c4\uc5d0 \ub530\ub974\uba74 \uc911\uad6d Livzon Pharmaceutical Group\uc774 \uc804\uc561 \ucd9c\uc790\ud55c \uc2f1\uac00\ud3ec\ub974 \uc18c\uc7ac \ubc95\uc778 Lian SGP\ub294 \uc57d 6\uc870\ub3d9(\uc57d 2\uc5b5 2,700\ub9cc \ub2ec\ub7ec, \uc57d 3,400\uc5b5\uc6d0)\uc5d0 Imexpharm \uc8fc\uc2dd 1\uc5b5450\ub9cc\uc8fc\ub97c \ub9e4\uc785\ud574 \ud68c\uc0ac \uc9c0\ubd84 67.8%\ub97c \ud655\ubcf4\ud588\ub2e4. YKVN\uc740 \ud638\ucc0c\ubbfc\uc2dc \uae30\ubc18\uc758 Managing Partner\uc778<\/p>\n","protected":false},"author":13501,"featured_media":684996,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","meta-author":""},"categories":[8398,8532],"tags":[149270,189738,189745,189742,189741,189746,116030,189743,189740,124792,189744,154755,150497,171082,189734,189736,189735,189737,189733,138624,189739,150595],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.7 (Yoast SEO v17.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<meta name=\"description\" content=\"YKVN\uacfc Allens\uac00 \uacf5\uac1c\ub9e4\uc218\ub97c \ud1b5\ud574 \ubca0\ud2b8\ub0a8 \uc81c\uc57d \ub300\uae30\uc5c5 Imexpharm\uc758 \uacbd\uc601\uad8c \uc9c0\ubd84\uc744 \uc778\uc218\ud55c Lian SGP \uce21\uacfc \ub9e4\ub3c4\uc778 \ud55c\uad6d SK\uadf8\ub8f9\uc744 \uac01\uac01 \uc790\ubb38\ud588\ub2e4.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/\" \/>\n<meta property=\"og:locale\" content=\"ko_KR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"YKVN\u00b7Allens, 3400\uc5b5 \uaddc\ubaa8 SK\uadf8\ub8f9 \uc81c\uc57d\uc0ac \ub9e4\uac01 \uac70\ub798 \uc790\ubb38\" \/>\n<meta property=\"og:description\" content=\"YKVN\uacfc Allens\uac00 \uacf5\uac1c\ub9e4\uc218\ub97c \ud1b5\ud574 \ubca0\ud2b8\ub0a8 \uc81c\uc57d \ub300\uae30\uc5c5 Imexpharm\uc758 \uacbd\uc601\uad8c \uc9c0\ubd84\uc744 \uc778\uc218\ud55c Lian SGP \uce21\uacfc \ub9e4\ub3c4\uc778 \ud55c\uad6d SK\uadf8\ub8f9\uc744 \uac01\uac01 \uc790\ubb38\ud588\ub2e4.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/\" \/>\n<meta property=\"og:site_name\" content=\"Law.asia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T07:23:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-27T03:13:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/law.asia\/wp-content\/uploads\/2026\/05\/YKVN-Allens-drive-USD227m-Vietnam-pharma-giant-acquisition.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:site\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Website team 05\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\ubd84\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/law.asia\/ko\/#organization\",\"name\":\"Law.asia\",\"url\":\"https:\/\/law.asia\/ko\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\",\"https:\/\/www.instagram.com\/law.asia_\/?hl=en\",\"https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/\",\"https:\/\/www.youtube.com\/@Law.asiaLimited\",\"https:\/\/twitter.com\/ablj_insights\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ko\/#logo\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"contentUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"width\":152,\"height\":152,\"caption\":\"Law.asia\"},\"image\":{\"@id\":\"https:\/\/law.asia\/ko\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/law.asia\/ko\/#website\",\"url\":\"https:\/\/law.asia\/ko\/\",\"name\":\"Law.asia\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/law.asia\/ko\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/law.asia\/ko\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ko-KR\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#primaryimage\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/law.asia\/wp-content\/uploads\/2026\/05\/YKVN-Allens-drive-USD227m-Vietnam-pharma-giant-acquisition.jpg\",\"contentUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2026\/05\/YKVN-Allens-drive-USD227m-Vietnam-pharma-giant-acquisition.jpg\",\"width\":900,\"height\":600,\"caption\":\"Vietnam Pharma Acquisition\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#webpage\",\"url\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/\",\"name\":\"YKVN\\u00b7Allens, 3400\\uc5b5 \\uaddc\\ubaa8 SK\\uadf8\\ub8f9 \\uc81c\\uc57d\\uc0ac \\ub9e4\\uac01 \\uac70\\ub798 \\uc790\\ubb38 | Law.asia\",\"isPartOf\":{\"@id\":\"https:\/\/law.asia\/ko\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#primaryimage\"},\"datePublished\":\"2026-05-26T07:23:29+00:00\",\"dateModified\":\"2026-05-27T03:13:47+00:00\",\"description\":\"YKVN\\uacfc Allens\\uac00 \\uacf5\\uac1c\\ub9e4\\uc218\\ub97c \\ud1b5\\ud574 \\ubca0\\ud2b8\\ub0a8 \\uc81c\\uc57d \\ub300\\uae30\\uc5c5 Imexpharm\\uc758 \\uacbd\\uc601\\uad8c \\uc9c0\\ubd84\\uc744 \\uc778\\uc218\\ud55c Lian SGP \\uce21\\uacfc \\ub9e4\\ub3c4\\uc778 \\ud55c\\uad6d SK\\uadf8\\ub8f9\\uc744 \\uac01\\uac01 \\uc790\\ubb38\\ud588\\ub2e4.\",\"breadcrumb\":{\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#breadcrumb\"},\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#webpage\"},\"author\":{\"@id\":\"https:\/\/law.asia\/ko\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b\"},\"headline\":\"YKVN\\u00b7Allens, 3400\\uc5b5 \\uaddc\\ubaa8 SK\\uadf8\\ub8f9 \\uc81c\\uc57d\\uc0ac \\ub9e4\\uac01 \\uac70\\ub798 \\uc790\\ubb38\",\"datePublished\":\"2026-05-26T07:23:29+00:00\",\"dateModified\":\"2026-05-27T03:13:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#webpage\"},\"wordCount\":50,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/law.asia\/ko\/#organization\"},\"image\":{\"@id\":\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2026\/05\/YKVN-Allens-drive-USD227m-Vietnam-pharma-giant-acquisition.jpg\",\"keywords\":[\"Allens\",\"EU-GMP\",\"Ho Anh Tuyet\",\"Imexpharm\",\"Lian SGP\",\"Linh Bui\",\"Linklaters\",\"Livzon Pharmaceutical Group\",\"SK Group\",\"SK\\uadf8\\ub8f9\",\"Truong Nhat Quang\",\"YKVN\",\"\\uacf5\\uac1c\\ub9e4\\uc218\",\"\\uae30\\uc5c5\\uacb0\\ud569 \\uc2e0\\uace0\",\"\\ubca0\\ud2b8\\ub0a8 M&amp;A\",\"\\ubca0\\ud2b8\\ub0a8 \\uad6d\\uac00\\uacbd\\uc7c1\\uc704\\uc6d0\\ud68c\",\"\\ubca0\\ud2b8\\ub0a8 \\uad6d\\uac00\\uc99d\\uad8c\\uc704\\uc6d0\\ud68c\",\"\\ubca0\\ud2b8\\ub0a8 \\uc0c1\\uc7a5\\uc0ac\",\"\\ubca0\\ud2b8\\ub0a8 \\uc81c\\uc57d \\uc0b0\\uc5c5\",\"\\uc2f1\\uac00\\ud3ec\\ub974 \\ud22c\\uc790\",\"\\uc81c\\uc57d\\uc0ac \\uc778\\uc218\",\"\\ud06c\\ub85c\\uc2a4\\ubcf4\\ub354 \\uac70\\ub798\"],\"articleSection\":[\"Asia Business Law Journal\",\"\\ub274\\uc2a4\"],\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\/\/law.asia\/#organization\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/law.asia\/ko\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b\",\"name\":\"Website team 05\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ko\/#personlogo\",\"inLanguage\":\"ko-KR\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9aabbf305ce0ba4ee191f1c8271609b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9aabbf305ce0ba4ee191f1c8271609b1?s=96&d=mm&r=g\",\"caption\":\"Website team 05\"},\"url\":\"https:\/\/law.asia\/ko\/author\/johnmanson\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"description":"YKVN\uacfc Allens\uac00 \uacf5\uac1c\ub9e4\uc218\ub97c \ud1b5\ud574 \ubca0\ud2b8\ub0a8 \uc81c\uc57d \ub300\uae30\uc5c5 Imexpharm\uc758 \uacbd\uc601\uad8c \uc9c0\ubd84\uc744 \uc778\uc218\ud55c Lian SGP \uce21\uacfc \ub9e4\ub3c4\uc778 \ud55c\uad6d SK\uadf8\ub8f9\uc744 \uac01\uac01 \uc790\ubb38\ud588\ub2e4.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/","og_locale":"ko_KR","og_type":"article","og_title":"YKVN\u00b7Allens, 3400\uc5b5 \uaddc\ubaa8 SK\uadf8\ub8f9 \uc81c\uc57d\uc0ac \ub9e4\uac01 \uac70\ub798 \uc790\ubb38","og_description":"YKVN\uacfc Allens\uac00 \uacf5\uac1c\ub9e4\uc218\ub97c \ud1b5\ud574 \ubca0\ud2b8\ub0a8 \uc81c\uc57d \ub300\uae30\uc5c5 Imexpharm\uc758 \uacbd\uc601\uad8c \uc9c0\ubd84\uc744 \uc778\uc218\ud55c Lian SGP \uce21\uacfc \ub9e4\ub3c4\uc778 \ud55c\uad6d SK\uadf8\ub8f9\uc744 \uac01\uac01 \uc790\ubb38\ud588\ub2e4.","og_url":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/","og_site_name":"Law.asia","article_publisher":"https:\/\/www.facebook.com\/AsiaBusinessLaw\/","article_published_time":"2026-05-26T07:23:29+00:00","article_modified_time":"2026-05-27T03:13:47+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/law.asia\/wp-content\/uploads\/2026\/05\/YKVN-Allens-drive-USD227m-Vietnam-pharma-giant-acquisition.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@ablj_insights","twitter_site":"@ablj_insights","twitter_misc":{"Written by":"Website team 05","Est. reading time":"2\ubd84"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/law.asia\/ko\/#organization","name":"Law.asia","url":"https:\/\/law.asia\/ko\/","sameAs":["https:\/\/www.facebook.com\/AsiaBusinessLaw\/","https:\/\/www.instagram.com\/law.asia_\/?hl=en","https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/","https:\/\/www.youtube.com\/@Law.asiaLimited","https:\/\/twitter.com\/ablj_insights"],"logo":{"@type":"ImageObject","@id":"https:\/\/law.asia\/ko\/#logo","inLanguage":"ko-KR","url":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","width":152,"height":152,"caption":"Law.asia"},"image":{"@id":"https:\/\/law.asia\/ko\/#logo"}},{"@type":"WebSite","@id":"https:\/\/law.asia\/ko\/#website","url":"https:\/\/law.asia\/ko\/","name":"Law.asia","description":"","publisher":{"@id":"https:\/\/law.asia\/ko\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/law.asia\/ko\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ko-KR"},{"@type":"ImageObject","@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#primaryimage","inLanguage":"ko-KR","url":"https:\/\/law.asia\/wp-content\/uploads\/2026\/05\/YKVN-Allens-drive-USD227m-Vietnam-pharma-giant-acquisition.jpg","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2026\/05\/YKVN-Allens-drive-USD227m-Vietnam-pharma-giant-acquisition.jpg","width":900,"height":600,"caption":"Vietnam Pharma Acquisition"},{"@type":"WebPage","@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#webpage","url":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/","name":"YKVN\u00b7Allens, 3400\uc5b5 \uaddc\ubaa8 SK\uadf8\ub8f9 \uc81c\uc57d\uc0ac \ub9e4\uac01 \uac70\ub798 \uc790\ubb38 | Law.asia","isPartOf":{"@id":"https:\/\/law.asia\/ko\/#website"},"primaryImageOfPage":{"@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#primaryimage"},"datePublished":"2026-05-26T07:23:29+00:00","dateModified":"2026-05-27T03:13:47+00:00","description":"YKVN\uacfc Allens\uac00 \uacf5\uac1c\ub9e4\uc218\ub97c \ud1b5\ud574 \ubca0\ud2b8\ub0a8 \uc81c\uc57d \ub300\uae30\uc5c5 Imexpharm\uc758 \uacbd\uc601\uad8c \uc9c0\ubd84\uc744 \uc778\uc218\ud55c Lian SGP \uce21\uacfc \ub9e4\ub3c4\uc778 \ud55c\uad6d SK\uadf8\ub8f9\uc744 \uac01\uac01 \uc790\ubb38\ud588\ub2e4.","breadcrumb":{"@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#breadcrumb"},"inLanguage":"ko-KR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home"}]},{"@type":"Article","@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#article","isPartOf":{"@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#webpage"},"author":{"@id":"https:\/\/law.asia\/ko\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b"},"headline":"YKVN\u00b7Allens, 3400\uc5b5 \uaddc\ubaa8 SK\uadf8\ub8f9 \uc81c\uc57d\uc0ac \ub9e4\uac01 \uac70\ub798 \uc790\ubb38","datePublished":"2026-05-26T07:23:29+00:00","dateModified":"2026-05-27T03:13:47+00:00","mainEntityOfPage":{"@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#webpage"},"wordCount":50,"commentCount":0,"publisher":{"@id":"https:\/\/law.asia\/ko\/#organization"},"image":{"@id":"https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#primaryimage"},"thumbnailUrl":"https:\/\/law.asia\/wp-content\/uploads\/2026\/05\/YKVN-Allens-drive-USD227m-Vietnam-pharma-giant-acquisition.jpg","keywords":["Allens","EU-GMP","Ho Anh Tuyet","Imexpharm","Lian SGP","Linh Bui","Linklaters","Livzon Pharmaceutical Group","SK Group","SK\uadf8\ub8f9","Truong Nhat Quang","YKVN","\uacf5\uac1c\ub9e4\uc218","\uae30\uc5c5\uacb0\ud569 \uc2e0\uace0","\ubca0\ud2b8\ub0a8 M&amp;A","\ubca0\ud2b8\ub0a8 \uad6d\uac00\uacbd\uc7c1\uc704\uc6d0\ud68c","\ubca0\ud2b8\ub0a8 \uad6d\uac00\uc99d\uad8c\uc704\uc6d0\ud68c","\ubca0\ud2b8\ub0a8 \uc0c1\uc7a5\uc0ac","\ubca0\ud2b8\ub0a8 \uc81c\uc57d \uc0b0\uc5c5","\uc2f1\uac00\ud3ec\ub974 \ud22c\uc790","\uc81c\uc57d\uc0ac \uc778\uc218","\ud06c\ub85c\uc2a4\ubcf4\ub354 \uac70\ub798"],"articleSection":["Asia Business Law Journal","\ub274\uc2a4"],"inLanguage":"ko-KR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/law.asia\/ko\/ykvn-allens-lian-sgp-imexpharm-sk-group-vietnam-pharma-acquisition\/#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/law.asia\/#organization"}},{"@type":"Person","@id":"https:\/\/law.asia\/ko\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b","name":"Website team 05","image":{"@type":"ImageObject","@id":"https:\/\/law.asia\/ko\/#personlogo","inLanguage":"ko-KR","url":"https:\/\/secure.gravatar.com\/avatar\/9aabbf305ce0ba4ee191f1c8271609b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9aabbf305ce0ba4ee191f1c8271609b1?s=96&d=mm&r=g","caption":"Website team 05"},"url":"https:\/\/law.asia\/ko\/author\/johnmanson\/"}]}},"_links":{"self":[{"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/posts\/685020"}],"collection":[{"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/users\/13501"}],"replies":[{"embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/comments?post=685020"}],"version-history":[{"count":3,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/posts\/685020\/revisions"}],"predecessor-version":[{"id":685086,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/posts\/685020\/revisions\/685086"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/media\/684996"}],"wp:attachment":[{"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/media?parent=685020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/categories?post=685020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/law.asia\/ko\/wp-json\/wp\/v2\/tags?post=685020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}